BGI Genomics Co., Ltd. (SZSE:300676) agreed to acquire 15.65% stake in BGI Shuji Biotechnology (Shenzhen) Co., Ltd. for CNY 55.2 million on March 29, 2023. BGI Genomics will use own funds of CNY 55.20 million for the transaction. BGI Shuji Biotechnology (Shenzhen) has reported Total assets of CNY 27.6148 million, net assets of CNY -54.0547 million, revenue of CNY 0.9826 million and net profit of CNY -25.5497 million on December 31, 2022.

The board of BGI Genomics has approved the transaction on March 29, 2023.